Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and Prospects

Abstract excerpt

Lung cancer ranks among the most prevalent malignant tumors, characterized by delayed diagnosis, limited treatment efficacy, and generally poor prognosis. Consequently, there is an urgent demand for effective treatments. Neoantigen-based immunotherapy emerged as a promising strategy in lung cancer treatment as ideal targets for immunotherapy interventions. Neoantigens are tumor-specific antigens produced by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Immunotherapy and Biomarkers
• Share to Immunotherapy and Immune Responses
• Share to vaccines and immunoinformatics approaches